ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,011.12
      -0.22%
      US Tech 100
      16,903.20
      -0.77%
      Dow Jones
      37,775.38
      0.06%
      Brent Oil
      88.785
      2.74%
      Bitcoin
      61,800.55
      -2.69%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Idera Pharmaceuticals Inc (IDRA)

      7. Idera Pharmaceuticals Inc (IDRA) News

      IDRA

      Idera Pharmaceuticals (IDRA)

      Idera Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IDRA
      DateTimeSourceHeadlineSymbolCompany
      06/29/20234:31PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
      06/23/20237:20PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/17/20239:50AMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/15/20235:08PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
      05/12/20234:25PMEdgar (US Regulatory)Report of Proposed Sale of Securities (144)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/13/20234:32PMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/10/20234:41PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
      04/03/20236:00AMEdgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      03/30/20234:52PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      03/28/202311:29AMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:IDRAIdera Pharmaceuticals Inc
      03/28/202311:22AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDRAIdera Pharmaceuticals Inc
      02/14/20235:00PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
      02/03/20234:35PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      02/01/20234:44PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IDRAIdera Pharmaceuticals Inc
      01/30/20234:32PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
      01/18/20234:55PMEdgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:IDRAIdera Pharmaceuticals Inc
      01/18/20234:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IDRAIdera Pharmaceuticals Inc
      01/17/20238:00AMGlobeNewswire Inc.Idera Pharmaceuticals Announces Name Change to Aceragen, Inc. and Provides Near-Term Strategic OutlookNASDAQ:IDRAIdera Pharmaceuticals Inc
      01/13/20238:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      01/11/20238:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      12/22/20225:21PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:IDRAIdera Pharmaceuticals Inc
      12/09/20224:50PMEdgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
      11/23/20224:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      11/17/20225:22PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      11/14/20224:59PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IDRAIdera Pharmaceuticals Inc
      11/14/20224:58PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
      11/14/20224:05PMGlobeNewswire Inc.Idera Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:IDRAIdera Pharmaceuticals Inc
      10/05/20224:36PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:IDRAIdera Pharmaceuticals Inc
      10/03/20225:11PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:IDRAIdera Pharmaceuticals Inc
      09/30/20224:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IDRAIdera Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:IDRA